• Home
  • Test Directory
  • Send Samples
  • Resources
  • R and D
  • News Room
  • About Us
  • Contact Us
Skip Navigation LinksHOME > TEST DIRECTORY
Customer Service
For product ordering and shipping information, please visit the SEND SAMPLES section of our site or call Client Services 866-262-7943.

Medical Professionals
For technical questions regarding the use of our products, please contact Client Services
866-262-7943

Ambry Test®


The content on this page is intended for healthcare professionals. If you are a patient researching testing options for a disease, we want you to remember that all health information should be discussed with your doctor.

The proprietary Ambry Test® combines scanning and sequencing technologies to analyze a gene’s entire coding region plus surrounding critical introns. Capable of identifying approximately 99% of all disease-causing mutations of the CFTR gene, the company’s reputable Cystic Fibrosis test has an unrivaled detection rate across all ethnic groups. The Company also created the world’s first and only comprehensive genetic test for three principal genes (PRSS1, SPINK1 and CFTR) associated with Chronic and Hereditary Pancreatitis. Ambry Genetics’ most recent developments focus on diagnosis of pulmonary conditions, including Alpha-1-Antitrypsin Deficiency, Surfactant Protein B Deficiency, Surfactant Protein C Deficiency, and ABCA3-Related Surfactant Deficiency.


Disclaimer:

This test was developed and its performance characteristics were determined by Ambry Genetics Corporation. The laboratory is regulated under the Clinical Laboratory Improvement Amendments 2003 as qualified to perform nonwaived testing. Although molecular tests are highly accurate, rare diagnostic errors may occur. The Ambry Test: Full Gene Analysis (FGA) analyzes the following types of mutations: nucleotide substitutions, small deletions, small insertions, and small indels. In addition, the Ambry Test: Gross Del/Dup analyzes the following types of mutations: gross insertions and gross deletions. Both methods technically could miss gross rearrangement mutations and other unknown abnormalities. The pattern of mutation types varies with the gene tested and the Ambry Test detects a high but variable percentage of known and unknown mutants of the classes stated. A negative result from the analysis cannot rule out the possibility that the tested individual carries a rare unexamined mutation or mutation in the undetectable group. A report does not represent medical advice. Any questions, suggestions, or concerns regarding interpretation of results should be forwarded to a genetic counselor, medical geneticist, or physician skilled in interpretation of the relevant medical literature. References are available upon request.